Mdm2：待解决的问题。
Mdm2: Open questions.
机构信息
Institute of Molecular Oncology, Göttingen Center of Molecular Biosciences (GZMB), University Medical Center Göttingen, Göttingen, Germany.
Institute for Advanced Study, Princeton, NJ, USA.
出版信息
Cancer Sci. 2020 Jul;111(7):2203-2211. doi: 10.1111/cas.14433. Epub 2020 Jun 11.
Abstract
The Mdm2 oncoprotein and its association with p53 were discovered 30 years ago, and a cornucopia of activities and regulatory pathways have been associated with it. In this review, we will raise questions about Mdm2 and its cousin Mdm4 that we consider worth pursuing in future research, reaching from molecular structures and intracellular activities all the way to development, evolution, and cancer therapy. We anticipate that such research will not only close a few gaps in our knowledge but could add new dimensions to our current view. This compilation of questions contributes to the preparation for the 10th Mdm2 Workshop in Tokyo.
摘要
Mdm2 癌蛋白及其与 p53 的关联在 30 年前被发现，此后与之相关的活动和调控途径层出不穷。在这篇综述中，我们将提出一些关于 Mdm2 及其同源物 Mdm4 的问题，这些问题是我们认为值得在未来的研究中探讨的，涵盖了从分子结构和细胞内活动到发育、进化和癌症治疗的各个方面。我们预计，这类研究不仅能够填补我们知识体系中的一些空白，还能为我们现有的认识增添新的维度。这些问题的提出是为了筹备在东京举行的第十届 Mdm2 研讨会。
相似文献
1
Mdm2: Open questions.Mdm2：待解决的问题。
Cancer Sci. 2020 Jul;111(7):2203-2211. doi: 10.1111/cas.14433. Epub 2020 Jun 11.
2
Mdmx and Mdm2: brothers in arms?Mdmx和Mdm2：战友？
Cell Cycle. 2004 Jul;3(7):900-4. Epub 2004 Jul 2.
3
MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.MDM2而非MDM4通过对MYCN翻译的p53非依赖性调控促进视网膜母细胞瘤细胞增殖。
Oncogene. 2017 Mar 30;36(13):1760-1769. doi: 10.1038/onc.2016.350. Epub 2016 Oct 17.
4
MDM2, MDMX and p53 in oncogenesis and cancer therapy.MDM2、MDMX 和 p53 在肿瘤发生和癌症治疗中的作用。
Nat Rev Cancer. 2013 Feb;13(2):83-96. doi: 10.1038/nrc3430. Epub 2013 Jan 10.
5
Dynamics in the p53-Mdm2 ubiquitination pathway.p53-Mdm2泛素化途径中的动力学
Cell Cycle. 2004 Jul;3(7):895-9. Epub 2004 Jul 2.
6
The MDM2 gene family.MDM2基因家族。
Biomol Concepts. 2014 Mar;5(1):9-19. doi: 10.1515/bmc-2013-0027.
7
p53 Regulation: a family affair.p53调控：家族之事。
Cell Cycle. 2004 Jul;3(7):884-5. doi: 10.4161/cc.3.7.996. Epub 2004 Jul 2.
8
A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.一种缺失富含脯氨酸结构域的小鼠p53突变体可挽救Mdm4缺陷，并为Mdm2-Mdm4-p53调控网络提供了深入见解。
Cancer Cell. 2006 Apr;9(4):273-85. doi: 10.1016/j.ccr.2006.03.014.
9
MDM2 and MDM4: p53 regulators as targets in anticancer therapy.MDM2与MDM4：作为抗癌治疗靶点的p53调节因子
Int J Biochem Cell Biol. 2007;39(7-8):1476-82. doi: 10.1016/j.biocel.2007.03.022. Epub 2007 Apr 8.
10
Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation.升高的MDM2通过促进MDMX降解增强p53-MDM2结合抑制剂的凋亡活性。
Cell Cycle. 2008 Jun 1;7(11):1604-12. doi: 10.4161/cc.7.11.5929. Epub 2008 Mar 17.
引用本文的文献
1
Chromothripsis.染色体碎裂
Methods Mol Biol. 2025;2968:3-33. doi: 10.1007/978-1-0716-4750-9_1.
2
A cancer persistent DNA repair circuit driven by MDM2, MDM4 (MDMX), and mutant p53 for recruitment of MDC1 and 53BP1 on chromatin.由MDM2、MDM4（MDMX）和突变型p53驱动的癌症持续性DNA修复回路，用于在染色质上募集MDC1和53BP1。
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf627.
3
Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer.截短的DAPK变体可恢复肿瘤抑制活性，并在高级别浆液性卵巢癌中与标准疗法协同作用。
Cancers (Basel). 2025 Jun 8;17(12):1910. doi: 10.3390/cancers17121910.
4
The CRISPR-Cas revolution in head and neck cancer: a new era of targeted therapy.CRISPR-Cas技术在头颈癌领域的变革：靶向治疗的新时代。
Funct Integr Genomics. 2025 May 30;25(1):113. doi: 10.1007/s10142-025-01612-2.
5
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.通过激活p53或抑制细胞周期来中断热休克因子1-热休克蛋白90轴，从而增强结直肠癌治疗效果。
Cell Death Differ. 2025 Apr 9. doi: 10.1038/s41418-025-01502-x.
6
Targeting MDM2 affects spastin protein levels and functions: implications for HSP treatment.靶向MDM2会影响痉挛蛋白水平和功能：对遗传性痉挛性截瘫治疗的启示
Cell Death Discov. 2025 Feb 7;11(1):53. doi: 10.1038/s41420-025-02333-y.
7
Adult glioblastoma with Lynch syndrome-associated mismatch repair deficiency forms a distinct high-risk molecular subgroup.伴有林奇综合征相关错配修复缺陷的成人胶质母细胞瘤形成一个独特的高危分子亚组。
Free Neuropathol. 2024 Dec 10;5:32. doi: 10.17879/freeneuropathology-2024-5892. eCollection 2024 Jan.
8
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future.MDM2 抑制剂在癌症治疗中的应用：过去、现在与未来。
Pharmacol Rev. 2024 May 2;76(3):414-453. doi: 10.1124/pharmrev.123.001026.
9
"The 10th International MDM2 Workshop": Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in Asia.“第十届 MDM2 研讨会”：开启 MDM2 和 p53 研究的新途径，第一届亚洲 MDM2 研讨会。
Genes Cells. 2024 Jun;29(6):451-455. doi: 10.1111/gtc.13114. Epub 2024 Mar 29.
10
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.通过激活p53或抑制细胞周期来阻断HSF1-HSP90轴，从而增强结直肠癌治疗效果。
bioRxiv. 2024 Feb 26:2024.02.22.581507. doi: 10.1101/2024.02.22.581507.
本文引用的文献
1
Germline mutation of , a major p53 regulator, in a familial syndrome of defective telomere maintenance., 一种主要的 p53 调节因子，在端粒维持缺陷的家族综合征中的胚系突变。
Sci Adv. 2020 Apr 10;6(15):eaay3511. doi: 10.1126/sciadv.aay3511. eCollection 2020 Apr.
2
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery.蛋白水解靶向嵌合体作为治疗方法和生物发现工具。
Cell. 2020 Apr 2;181(1):102-114. doi: 10.1016/j.cell.2019.11.031. Epub 2020 Jan 16.
3
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.PRMT5-MDM4 轴的调控对黑色素瘤中 CDK4/6 抑制剂的反应至关重要。
Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):17990-18000. doi: 10.1073/pnas.1901323116. Epub 2019 Aug 22.
4
p53 modifications: exquisite decorations of the powerful guardian.p53 修饰：强大守护者的精致装饰。
J Mol Cell Biol. 2019 Jul 19;11(7):564-577. doi: 10.1093/jmcb/mjz060.
5
Next-generation characterization of the Cancer Cell Line Encyclopedia.下一代癌症细胞系百科全书的特征描述。
Nature. 2019 May;569(7757):503-508. doi: 10.1038/s41586-019-1186-3. Epub 2019 May 8.
6
The long and the short of it: the MDM4 tail so far.长话短说：迄今为止的 MDM4 尾巴。
J Mol Cell Biol. 2019 Mar 1;11(3):231-244. doi: 10.1093/jmcb/mjz007.
7
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression.发现 MD-224 是一种首创的、高效能的、有效的蛋白酶体靶向嵌合体，可使鼠双微体 2 降解剂完全且持久地肿瘤消退。
J Med Chem. 2019 Jan 24;62(2):448-466. doi: 10.1021/acs.jmedchem.8b00909. Epub 2018 Dec 10.
8
Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication.染色质修饰物 Mdm2 和 RNF2 可防止损害 DNA 复制的 RNA:DNA 杂交体的形成。
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11311-E11320. doi: 10.1073/pnas.1809592115. Epub 2018 Nov 9.
9
Senolytics improve physical function and increase lifespan in old age.衰老细胞清除疗法可改善老年的身体机能并延长寿命。
Nat Med. 2018 Aug;24(8):1246-1256. doi: 10.1038/s41591-018-0092-9. Epub 2018 Jul 9.
10
Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63.卵母细胞 DNA 损伤质量控制需要 CHK2 和 CK1 的连续相互作用以激活 p63。
Nat Struct Mol Biol. 2018 Mar;25(3):261-269. doi: 10.1038/s41594-018-0035-7. Epub 2018 Feb 26.
Zotero 插件